Literature DB >> 7261252

In vitro cell growth inhibition by metallocene dichlorides.

P Köpf-Maier, W Wagner, H Köpf.   

Abstract

The in vitro growth-inhibiting potencies of titanocene dichloride (TDC), zirconocene dichloride (ZDC), hafnocene dichloride (HDC), vanadocene dichloride (VDC), and molybdocene dichloride (MDC) against Ehrlich ascites tumor (EAT) cells cultured in viro as permanently growing suspension cultures were determined. The most striking growth-suppression activity was detected for VDC. A VDC concentration as low as 5. 10(-6) mol/l effects a highly significant diminution of cell proliferation. TDC and MDC inhibit cellular growth only concentration of 5 . 10(-4) or 10(-3) mol/l, respectively, whereas ZDC and HDC, which are ineffective against EAT cells in vivo, require higher concentration levels. The growth inhibition is caused by a cytotoxic action of the metallocene dichlorides, as is demonstrated in the case of VDC and TDC by differentiation of live and dead EAT cells by means of the dye lissamine green.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7261252     DOI: 10.1007/BF00434391

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  6 in total

1.  [Molybdocene dichloride as an antitumor agent (author's transl)].

Authors:  P Köpf-Maier; M Leitner; R Voigtländer; H Köpf
Journal:  Z Naturforsch C Biosci       Date:  1979-12

2.  Tumor inhibition by titanocene dichloride: first clues to the mechanism of action.

Authors:  P Köpf-Maier; H Köpf
Journal:  Naturwissenschaften       Date:  1980-08

3.  [Tumor inhibition by metallocenes: effect of titanocene, zirconocene, and hafnocene dichlorides on Ehrlich ascites tumor in mice (author's transl)].

Authors:  P Köpf-Maier; B Hesse; H Köpf
Journal:  J Cancer Res Clin Oncol       Date:  1980-01       Impact factor: 4.553

4.  Action of Cis-dichlorodiammineplatinum(II) (NSC-119875) at ehe cellular level.

Authors:  B Drewinko; J A Gottlieb
Journal:  Cancer Chemother Rep       Date:  1975 May-Jun

5.  The interaction of an anti-tumour platinum complex with DNA.

Authors:  I A Roos
Journal:  Chem Biol Interact       Date:  1977-01       Impact factor: 5.192

6.  Tumor inhibition by metallocenes: antitumor activity of titanocene dihalides (C5H5)2TiX2 (X=F, Cl, Br, I, NCS) and their application in buffered solutions as a method for suppressing drug-induced side effects.

Authors:  P Köpf-Maier; B Hesse; R Voigtländer; H Köpf
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

  6 in total
  9 in total

1.  Immunologic response to the treatment of Ehrlich ascites tumor with titanocene dichloride.

Authors:  P Köpf-Maier; A Hesse
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

2.  Development of necroses, virus activation and giant cell formation after treatment of Ehrlich ascites tumor with metallocene dichlorides.

Authors:  P Köpf-Maier
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

3.  Vanadocene dichloride induces apoptosis in HeLa cells through depolymerization of microtubules and inhibition of Eg5.

Authors:  Susobhan Mahanty; Darpan Raghav; Krishnan Rathinasamy
Journal:  J Biol Inorg Chem       Date:  2021-05-31       Impact factor: 3.358

4.  Antitumor activity of bent metallocenes: electronic structure analysis using DFT computations.

Authors:  Dhurairajan Senthilnathan; Sundararajan Vaideeswaran; Ponnambalam Venuvanalingam; Gernot Frenking
Journal:  J Mol Model       Date:  2010-05-22       Impact factor: 1.810

5.  Interaction of metallocene dichlorides with apo-human transferrin: A spectroscopic study and cytotoxic activity against human cancer cell lines.

Authors:  Jorge R Güette Fernández; Xiomara Narváez Pita; Enrique Meléndez; Elsie I Parés Matos
Journal:  Int J Mol Biol (Edmond)       Date:  2020-07-31

Review 6.  Scope of organometallic compounds based on transition metal-arene systems as anticancer agents: starting from the classical paradigm to targeting multiple strategies.

Authors:  Mehvash Zaki; Suboot Hairat; Elham S Aazam
Journal:  RSC Adv       Date:  2019-01-24       Impact factor: 4.036

7.  Cytokinetic behavior of Ehrlich ascites tumor after in vivo treatment with cis-diamminedichloroplatinum(II) and metallocene dichlorides.

Authors:  P Köpf-Maier; W Wagner; E Liss
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

8.  Induction of cell arrest at G1/S and in G2 after treatment of Ehrlich ascites tumor cells with metallocene dichlorides and cis-platinum in vitro.

Authors:  P Köpf-Maier; W Wagner; E Liss
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

9.  A polymer-based drug delivery system for the antineoplastic agent bis(maltolato)oxovanadium in mice.

Authors:  J K Jackson; W Min; T F Cruz; S Cindric; L Arsenault; D D Von Hoff; D Degan; W L Hunter; H M Burt
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.